| PCI-24781 in Combination With Doxorubicin to Treat Sarcoma (NCT01027910) | Massachusetts General Hospital | 2009-02-01 |
| Pharmacokinetics and Safety of Single-Dose Telbivudine in Children and Adolescents With Chronic Hepatitis B (NCT00907894) | Novartis Pharmaceuticals | 2009-02-01 |
| Safety and Pharmacokinetic Comparison of Cilostazol SR and IR Formulations in Healthy Korean Volunteers (NCT01455558) | Severance Hospital | 2009-02-01 |
| Interaction Study of Clopidogrel 300/75 mg Given Alone or Concomitantly With Omeprazole 80 mg in Healthy Subjects (NCT01129375) | Sanofi | 2009-02-01 |
| An Open Dose-finding Study of Oral Applied Hexaminolevulinate (HAL) Imaging in Patients With Suspicion or High Risk of Neoplasia in the Colon (NCT01344902) | Photocure | 2009-02-01 |
| Safety and Immune Response to Preventive HIV Immunization With Adenovirus Serotype 5 or 35 Vector (NCT00801697) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-02-01 |
| Cardiac Stem Cell Infusion in Patients With Ischemic CardiOmyopathy (SCIPIO) (NCT00474461) | University of Louisville | 2009-02-01 |
| Safety, Tolerability, and Profile of Action of Drug in the Body of NN9535 in Healthy Male Japanese and Caucasian Subjects (NCT00851773) | Novo Nordisk A/S | 2009-02-01 |
| Pharmacokinetic Study of Ondansetron Administered as IR (Zofran) and MR (EUR1025) (NCT01036854) | Forest Laboratories | 2009-02-01 |
| A Phase 1-2 Study of CF102 in Patients With Advanced Hepatocellular Carcinoma (NCT00790218) | Can-Fite BioPharma | 2009-02-01 |
| Sorafenib With Irinotecan in Metastatic Colorectal Cancer (mCRC) and K-RAS Mutation (NCT00989469) | Institut du Cancer de Montpellier - Val d'Aurelle | 2009-02-01 |
| Bleeding Time Study With AZD6482, Clopidogrel and ASA (NCT00853450) | AstraZeneca | 2009-02-01 |
| Treatment of Traumatic Brain Injury With Hyperbaric Oxygen Therapy (NCT00810615) | San Antonio Military Medical Center | 2009-02-01 |
| A Study of Obinutuzumab in Combination With Chemotherapy in Participants With CD20+ B-Cell Follicular Non-Hodgkin's Lymphoma (NCT00825149) | Hoffmann-La Roche | 2009-02-01 |
| Fluorescein for Lymphatic Mapping and Sentinel Lymph Node (SLN) Biopsy in Patients With Stage I and II Malignant Melanoma (NCT00847522) | University of Utah | 2009-02-01 |
| Study to Investigate Safety and Response to 1 or 2 g Rectal Suppositories Containing 5 or 10 mg NRL001. (NCT00857467) | Norgine | 2009-02-01 |
| A Drug Interaction Study of VI-0521 With Metformin, Sitagliptan and Probenecid in Healthy Subjects. (NCT00842400) | VIVUS LLC | 2009-02-01 |
| Investigation of Drug-drug Interaction Between Clopidogrel and Fluoxetine (NCT00732290) | Centre Hospitalier Universitaire de Saint Etienne | 2009-02-01 |
| A Dose-Escalation Study to Assess the Safety and Tolerability of LX214 Ophthalmic Solution in Healthy Volunteers, Followed by an Open-Label Evaluation of LX214 in Patients With Keratoconjunctivitis Sicca (KCS) (NCT00851734) | Lux Biosciences, Inc. | 2009-02-01 |
| Study Evaluating the Safety and Efficacy of FOLFIRI Plus Cetuximab or FOLFOX Plus Cetuximab as First-line Therapy in Subjects With KRAS Wild-type Metastatic Colorectal Cancer (APEC-Study) (NCT00778830) | Merck KGaA, Darmstadt, Germany | 2009-02-01 |
| MRI Targeted Focal Laser Thermal Therapy of Prostate Cancer Followed by Radical Prostatectomy (NCT00805883) | University Health Network, Toronto | 2009-02-01 |
| E7080 in Combination With Carboplatin and Paclitaxel in Patients With Non-small Cell Lung Cancer (NSCLC) (NCT00832819) | Eisai Co., Ltd. | 2009-02-01 |
| Low-dose Challenge Model With Enterotoxigenic E Coli (NCT00844493) | Johns Hopkins Bloomberg School of Public Health | 2009-02-01 |
| EMD 525797 in Colorectal and Ovarian Cancer Patients With Liver Metastases (NCT00848510) | Merck KGaA, Darmstadt, Germany | 2009-02-01 |
| Everolimus (RAD001) and Carboplatin in Pretreated Metastatic Breast Cancer (NCT00930475) | Charite University, Berlin, Germany | 2009-02-01 |
| Phase I Trial of Inhaled Nitric Oxide to Treat Acute Pulmonary Embolism (NCT00848731) | Wake Forest University Health Sciences | 2009-02-01 |
| Massage Therapy and Port-a-Catheter Insertion (NCT00991770) | Boston Medical Center | 2009-02-01 |
| Evaluation of Exposure Reduction Using Region-of-Interest Fluoroscopy (X-ray Fovea Imaging) in Cardiac Interventions (NCT00817115) | Sunnybrook Health Sciences Centre | 2009-02-01 |
| A Phase 1, Randomized, Open-Label, Two-Way Crossover Study To Evaluate The Steady-State Effect Of Dimebon (PF 01913539) On The Single-Dose Pharmacokinetics And Pharmacodynamics Of Warfarin In Healthy Subjects (NCT00827034) | Pfizer | 2009-02-01 |
| A Phase 1/2, Open-Label, Dose-Escalation Study of JI-101, in Patients With Advanced Solid Tumors (NCT00842335) | Jubilant Innovation Ltd. | 2009-02-01 |
| Clinical Study of TUTI-16 in Asymptomatic HIV-1 Infected Subjects (NCT00848211) | Thymon, LLC | 2009-02-01 |
| Lactobacillus Farciminis and Hyperalgesia (NCT00852865) | Lallemand SAS | 2009-02-01 |
| Drug-Food Interaction Study of Seville Orange Juice and Colchicine (NCT00960193) | Mutual Pharmaceutical Company, Inc. | 2009-02-01 |
| MQX-503 Applied to the Hand Versus Nitroglycerin Ointment Applied to the Chest: A Pharmacokinetic Comparison (NCT00841594) | MediQuest Therapeutics | 2009-02-01 |
| Comparison of Fenofibric Acid Bioavailability From ABT-335 Capsules (NCT00839293) | Abbott | 2009-02-01 |
| A Study for Participants With Pancreatic Cancer (NCT00839332) | Eli Lilly and Company | 2009-02-01 |
| The Effects of Potassium Nitrate in Reducing Dentinal Hypersensitivity (NCT01587950) | GlaxoSmithKline | 2009-02-01 |
| Safety, Tolerability and PK Study of Single Doses of ABT-450 With and Without Ritonavir to Treat Hepatitis C Virus (HCV) Genotype 1 (NCT00850044) | AbbVie | 2009-02-01 |
| Sorafenib, Epirubicin, Ifosfamide, and Radiation Therapy Followed By Surgery in Treating Patients With High-Risk Stage II or Stage III Soft Tissue Sarcoma (NCT00822848) | OHSU Knight Cancer Institute | 2009-02-01 |
| GSK1349572 Mass Balance Study (NCT00828763) | GlaxoSmithKline | 2009-02-01 |
| Study to Investigate Effects of CAL-101 in Subjects With Allergic Rhinitis Exposed to Allergen in an Environmental Chamber (NCT00836914) | Gilead Sciences | 2009-02-01 |
| Hepatic Arterial Infusion of Nab-Paclitaxel in Patients With Metastatic Melanoma in the Liver (NCT00833807) | M.D. Anderson Cancer Center | 2009-02-01 |
| Study Evaluating Single Doses of GAP-134 (NCT00820521) | Wyeth is now a wholly owned subsidiary of Pfizer | 2009-02-01 |
| Clinical Trial of Gene Therapy for Leber Congenital Amaurosis Caused by RPE65 Mutations (NCT00821340) | Hadassah Medical Organization | 2009-02-01 |
| Drug-Drug Interaction - 3 Arm - Carboplatin/Paclitaxel, Dacarbazine (NCT00796991) | Bristol-Myers Squibb | 2009-02-01 |
| Investigation Of Safety And Pharmacokinetics Following A Single Oral Dose Of 300 Mg Maraviroc In Healthy Male Japanese Volunteers (NCT00821535) | ViiV Healthcare | 2009-02-01 |
| Bioavailability Study of Anti Nausea Medication With and Without Food (NCT00905190) | Forest Laboratories | 2009-02-01 |
| Pharmacokinetic Study To Evaluate Effect of Food and Diurnal Variation on ABT-869 (NCT00733187) | AbbVie (prior sponsor, Abbott) | 2009-02-01 |
| Comfort Level of Two Abdominal Compression Methods Used to Hold Patients Still While Undergoing Stereotactic Body Radiation Therapy for Lung Tumors (NCT00866086) | University of Texas Southwestern Medical Center | 2009-02-01 |
| A Study to Evaluate the Effect of Repeat Oral Doses of YM443 on Cardiac Repolarization in Healthy Adults (NCT00850746) | Astellas Pharma Inc | 2009-02-01 |
| Investigation of the Impact of Concomitant Use of Multiple Doses of Clopidogrel With Multiple Doses of Dabigatran Etexilate on the Pharmacokinetic and Pharmacodynamic Parameters in Healthy Male Subjects (NCT02171598) | Boehringer Ingelheim | 2009-02-01 |
| Balance System Study in Type 2 Diabetic Patients (NCT00872846) | Beta-Stim Ltd. | 2009-02-01 |
| Phase I Imaging Study Evaluating Dalotuzumab (MK0646) in Combination With Erlotinib for Patients With Non-Small Cell Lung Cancer (MK-0646-008) (NCT00729742) | Merck Sharp & Dohme LLC | 2009-02-01 |
| Study of Capsaicin Patch for the Management of Peripheral Neuropathic Pain (NCT02228928) | Samyang Biopharmaceuticals Corporation | 2009-02-01 |
| PEPI-TiDP23-C103: First-in-Human Study to Examine the Safety, Tolerability, and Plasma Pharmacokinetics of Increasing Single and Repeated Oral Doses of TMC558445 and of a Combined Single Day Dosing of Oral TMC558445 and Oral TMC310911 and Also Oral Darunavir (NCT00838760) | Tibotec Pharmaceuticals, Ireland | 2009-02-01 |
| Low Fat Diet and Multiple Sclerosis (NCT00852722) | Oregon Health and Science University | 2009-02-01 |
| Pharmacokinetics of LCZ696 in Subjects With Mild and Moderate Renal Impairment Compared to Healthy Subjects With Normal Renal Function (NCT01569815) | Novartis Pharmaceuticals | 2009-02-01 |
| Study of Escalating Doses of NRL001 Given in Slow-release Rectal Suppositories of Different Weights (NCT00850590) | Norgine | 2009-02-01 |
| Evaluating the Pharmacokinetics and Tolerance of Co-administration of Oral Multiple Dose of Ketoconazole and an IV (Bolus) Infusion of Eribulin in Patients With Advanced Solid Tumors (NCT01000376) | Eisai Limited | 2009-02-01 |
| Multiple Ascending Dose (MDX1105-01) (NCT00729664) | Bristol-Myers Squibb | 2009-02-01 |
| Haploidentical NK Cell Infusion in Malignant Melanoma (NCT00846833) | Seoul National University Hospital | 2009-02-01 |
| Mesenchymal Stem Cells and Subclinical Rejection (NCT00734396) | Leiden University Medical Center | 2009-02-01 |
| Safety, Tolerability and Preliminary Efficacy of FP-1201 in ALI and ARDS. Phase I/II (NCT00789685) | Faron Pharmaceuticals Ltd | 2009-02-01 |
| Exploratory Pharmacokinetic and Bioavailability Study of 2 Capsule Formulations of Torezolid Phosphate (NCT00876655) | Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2009-02-01 |
| Intravenous Dose-Escalation Study With ETI-204 in Adult Volunteers (NCT00829582) | Elusys Therapeutics | 2009-02-01 |
| Dose-escalation Study of Oral CX-4945 (NCT00891280) | Cylene Pharmaceuticals | 2009-02-01 |
| IVIg Therapy for Patients With Idiopathic Cardiomyopathy and Endomyocardial Biopsy Proven High PVB19 Viral Load (NCT00659386) | Maastricht University Medical Center | 2009-02-01 |
| Safety Study of Grass Pollen-derived Peptides to Treat Seasonal Allergic Rhinoconjunctivitis (NCT00833066) | BioTech Tools S.A. | 2009-02-01 |
| Interleukin-7 (CYT107) Treatment of Idiopathic CD4 Lymphocytopenia: Expansion of CD4 T Cells (ICICLE) (NCT00839436) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-02-01 |
| Study to Determine the Safety, Tolerability, and Pharmacokinetic (PK) Profile of EGT0001474 in Healthy Volunteers (NCT00854113) | Theracos | 2009-02-01 |
| Study of the Safety and Tolerability of PCI-32765 in Patients With Recurrent B Cell Lymphoma (NCT00849654) | Pharmacyclics LLC. | 2009-02-01 |
| A Pilot Study of Glioma Associated Antigen Vaccines in Conjunction with Poly-ICLC in Pediatric Gliomas (NCT01130077) | James Felker | 2009-02-01 |
| Laboratory-Treated T Cells and Ipilimumab in Treating Patients With Metastatic Melanoma (NCT00871481) | Fred Hutchinson Cancer Center | 2009-02-01 |
| Study of GemOx and Vandetanib in Advanced Solid Malignancy (NCT00660725) | Leonard Appleman | 2009-02-01 |
| Ipilimumab +/- Vaccine Therapy in Treating Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer (NCT00836407) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2009-02-01 |
| Evaluation of Safety and Efficacy of Shorttime TNI Treatment in Patients With COPD (NCT01686893) | Medical University Innsbruck | 2009-02-01 |
| A Study Evaluating Vaccination of Prostate Cancer Patients With Self Dendritic Cells Expressing MUC1 (NCT00852007) | Hamilton Health Sciences Corporation | 2009-02-01 |
| Viokase 16, Viokase16 Plus Nexium and Nexium Alone (NCT01142128) | University of Florida | 2009-02-01 |
| A Study of the Safety, Pharmacokinetics, and Pharmacodynamics of CNTO 3649 in Healthy Adults and Patients With Type 2 Diabetes Mellitus (NCT00882726) | Centocor, Inc. | 2009-02-01 |
| Comparison of Enteral Versus Parenteral Feeding in Healthy Human Subjects (NCT00856219) | Rutgers, The State University of New Jersey | 2009-02-01 |
| A Pilot Study to Examine the Role of Nitazoxanide to Prevent Recurrence of Hepatitis C After Transplantation (NCT01074203) | Mayo Clinic | 2009-02-01 |
| Safety of Acidform Lubricant in HIV-Uninfected Women (NCT00850837) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-02-01 |
| A Study to Assess the Pharmacologic Equivalence of Two Orlistat Dosage Forms (NCT01550926) | GlaxoSmithKline | 2009-02-01 |
| Hemin in Healthy Subjects (NCT00882804) | Mayo Clinic | 2009-02-01 |
| Targeting Interventions at Venues Where Risk of HIV Transmission is High (NCT01423357) | University of Zambia | 2009-02-01 |
| An Evaluation of the Pharmacokinetics and Safety of LIPO-102 in Healthy Volunteers (NCT00918606) | Neothetics, Inc | 2009-02-01 |
| The Influence of Probiotics in a Drinkable Yogurt on Skin Health (NCT00864188) | Société des Produits Nestlé (SPN) | 2009-02-01 |
| Randomized, Double Blind, Placebo-controlled Topical Resiquimod Adjuvant for NY-ESO-1 Protein Vaccination (NCT00821652) | Nina Bhardwaj | 2009-02-01 |
| Pilot Study of Behavioral Activation for Prolonged Grief (NCT01556048) | Anthony Papa | 2009-02-01 |
| Evaluation of Safety, Drug-Drug Interactions and Pharmacokinetic Profiles of Co-Administration of Betahistine With Olanzapine in Healthy Female Subjects (NCT00852956) | OBEcure Ltd. | 2009-02-01 |
| A Study on the Tolerability and Early Efficacy of hLF1-11 in Patients With Bacteremia Due to S. Epidermidis (NCT00509847) | AM-Pharma | 2009-02-01 |
| Safety and Efficacy of AGN 210669 Ophthalmic Solution in Patients With Ocular Hypertension or Primary Open-Angle Glaucoma (NCT00809848) | Allergan | 2009-02-01 |
| Ixabepilone and Hydroxychloroquine in Treating Patients With Metastatic Breast Cancer (NCT00765765) | University of Medicine and Dentistry of New Jersey | 2009-02-01 |
| A Multiple Dose Trial Evaluating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PF-04457845 in Healthy Volunteers (NCT00836082) | Pfizer | 2009-02-01 |
| A Proof of Concept Study to Evaluate the Antiviral Activity, Safety, and Pharmacokinetics of the CCR5 Antagonist TBR 652 in HIV 1-Infected, Antiretroviral Treatment-Experienced, CCR5 Antagonist-Naïve Patients (NCT01092104) | Tobira Therapeutics, Inc. | 2009-02-01 |
| Pharmacokinetic Drug Interaction Study of Dapagliflozin and Valsartan or Simvastatin in Healthy Subjects (NCT00839683) | AstraZeneca | 2009-02-01 |
| Cisplatin and Paclitaxel in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer (NCT00814086) | Gynecologic Oncology Group | 2009-02-01 |
| Double-Blind, Placebo Controlled Pilot Study of Octanoic Acid in Essential Tremor (NCT00848172) | National Institute of Neurological Disorders and Stroke (NINDS) | 2009-02-01 |
| Safety of SGI-1776, A PIM Kinase Inhibitor in Refractory Prostate Cancer and Relapsed/Refractory Non Hodgkin's Lymphoma (NCT00848601) | Astex Pharmaceuticals, Inc. | 2009-02-01 |
| Study of Chemoembolisation Using Irinotecan Bead Prior to Surgery in Metastatic Colorectal Cancer (NCT00844233) | Boston Scientific Corporation | 2009-02-01 |